[Management of the acute coronary syndrome under German diagnosis related groups in 2005/2006]

Eckart Frantz1

  • 1Abteilung für Innere Medizin, St. Josefs-Krankenhaus Potsdam-Sanssouci, Potsdam.

Herz
|December 7, 2005
PubMed

Insights

German hospitals often delay percutaneous coronary intervention (PCI) for acute coronary syndromes due to reimbursement policies. Current Diagnosis Related Groups incentives do not prioritize timely PCI transfers, impacting patient outcomes.

Area of Science:

  • Cardiology
  • Health Economics
  • Healthcare Policy

Context:

  • Patients with acute coronary syndromes in Germany are frequently admitted to hospitals lacking percutaneous coronary intervention (PCI) facilities.
  • This often results in significant delays in contact-to-balloon time, potentially increasing mortality and morbidity.
  • The German Diagnosis Related Groups (DRG) reimbursement system may incentivize practices that exacerbate these delays.

Purpose:

  • To discuss necessary changes in the German hospital reimbursement system concerning acute coronary syndrome (ACS) patient transfers.
  • To analyze the reasons behind the lack of successful proposals for reimbursement reform by the German Cardiac Society.
  • To examine the consequences of a reimbursement system driven by economic rather than medical considerations.

Summary:

  • The German hospital reimbursement system, based on Diagnosis Related Groups (DRG), does not prioritize timely percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS).
  • Hospitals may face financial disincentives for transferring ACS patients, and transport reimbursement is not covered.
  • Proposed changes to the reimbursement system have been unsuccessful, as the volume of ACS transfer cases is deemed too small to justify economic adjustments.

Impact:

  • The current reimbursement system may lead to suboptimal patient care for acute coronary syndromes due to economic, not medical, drivers.
  • Delayed PCI can negatively affect patient mortality and morbidity outcomes.
  • There is a need to align healthcare reimbursement policies with clinical best practices for critical conditions like ACS.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...